IL95525A - Pharmaceutical preparations containing a combination of two different plasminogen activators - Google Patents

Pharmaceutical preparations containing a combination of two different plasminogen activators

Info

Publication number
IL95525A
IL95525A IL9552590A IL9552590A IL95525A IL 95525 A IL95525 A IL 95525A IL 9552590 A IL9552590 A IL 9552590A IL 9552590 A IL9552590 A IL 9552590A IL 95525 A IL95525 A IL 95525A
Authority
IL
Israel
Prior art keywords
tpa
human
amino acids
acid sequence
amino acid
Prior art date
Application number
IL9552590A
Other languages
English (en)
Hebrew (he)
Other versions
IL95525A0 (en
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of IL95525A0 publication Critical patent/IL95525A0/xx
Publication of IL95525A publication Critical patent/IL95525A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/49—Urokinase; Tissue plasminogen activator
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
IL9552590A 1989-09-01 1990-08-30 Pharmaceutical preparations containing a combination of two different plasminogen activators IL95525A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB898919803A GB8919803D0 (en) 1989-09-01 1989-09-01 Pharmaceutical compositions

Publications (2)

Publication Number Publication Date
IL95525A0 IL95525A0 (en) 1991-06-30
IL95525A true IL95525A (en) 1995-03-30

Family

ID=10662394

Family Applications (1)

Application Number Title Priority Date Filing Date
IL9552590A IL95525A (en) 1989-09-01 1990-08-30 Pharmaceutical preparations containing a combination of two different plasminogen activators

Country Status (17)

Country Link
US (1) US5409700A (de)
EP (1) EP0421918B1 (de)
JP (1) JP2904893B2 (de)
KR (1) KR910005882A (de)
AT (1) ATE94407T1 (de)
AU (1) AU627927B2 (de)
CA (1) CA2024309C (de)
DD (1) DD299155A5 (de)
DE (1) DE69003342T2 (de)
DK (1) DK0421918T3 (de)
ES (1) ES2058871T3 (de)
GB (1) GB8919803D0 (de)
IE (1) IE63523B1 (de)
IL (1) IL95525A (de)
NZ (1) NZ235107A (de)
PT (1) PT95159B (de)
ZA (1) ZA906957B (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5994309A (en) * 1997-07-25 1999-11-30 Angstrom Pharmaceuticals, Inc. Anti-invasive and anti-angiogenic compositions and methods
WO2001032915A2 (en) 1999-11-04 2001-05-10 Genentech, Inc. Reversed-phase hplc assay for plasminogen activators

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL8503097A (nl) * 1985-11-11 1987-06-01 Leuven Res & Dev Vzw Geneesmiddel met thrombolytische werking.
NL8601240A (nl) * 1986-05-15 1987-12-01 Leuven Res & Dev Vzw Plasminogeenactivator en trombolytisch geneesmiddel.
FI100106B (fi) * 1986-12-05 1997-09-30 Novartis Ag Menetelmä plasminogeenin yksisäikeisen yhdistelmäaktivaattorin valmist amiseksi
SE462829B (sv) * 1989-01-10 1990-09-10 Kabigen Ab Trombolytiskt aktiva kompositioner innehaallande en modifierad plasminogenaktivator av vaevnadstyp samt en normal human t-pa, streptokinas eller humant urokinas

Also Published As

Publication number Publication date
NZ235107A (en) 1992-07-28
IE63523B1 (en) 1995-05-03
JP2904893B2 (ja) 1999-06-14
DE69003342D1 (de) 1993-10-21
DK0421918T3 (da) 1993-11-15
ATE94407T1 (de) 1993-10-15
IL95525A0 (en) 1991-06-30
DD299155A5 (de) 1992-04-02
GB8919803D0 (en) 1989-10-18
EP0421918A1 (de) 1991-04-10
CA2024309C (en) 2003-05-27
KR910005882A (ko) 1991-04-27
US5409700A (en) 1995-04-25
PT95159B (pt) 1997-08-29
JPH03130231A (ja) 1991-06-04
AU6205390A (en) 1991-03-07
ES2058871T3 (es) 1994-11-01
IE903179A1 (en) 1991-03-13
EP0421918B1 (de) 1993-09-15
DE69003342T2 (de) 1994-02-24
ZA906957B (en) 1991-06-26
CA2024309A1 (en) 1991-03-02
PT95159A (pt) 1991-05-22
AU627927B2 (en) 1992-09-03

Similar Documents

Publication Publication Date Title
EP0196920B1 (de) Degradierte Spezies eines Gewebeplasminogenaktivators, pharmazeutische Zubereitung und Verfahren zur Herstellung derselben
EP0155387B1 (de) Fibrinolytisches hybrides Protein, Verfahren zu seiner Herstellung und pharmazeutische Zubereitung
JP2559538B2 (ja) 組織プラスミノーゲン活性化因子の誘導体
US5830849A (en) Vampire bat salivary plasminogen activators
JP2003514790A (ja) 可逆的に不活性化された酸性化プラスミンの局所送達による血栓溶解の方法
WO1995026202A1 (en) Combinations of thrombolytically active proteins and anticoagulants, and uses thereof
JP2764264B2 (ja) 線溶活性増強剤
EP0307847B1 (de) Thrombolytisches Agens
US5681721A (en) Bifunctional urokinase variants with improved fibrinolytic characteristics and thrombin inhibiting effect
AU603062B2 (en) Novel tissue plasminogen activator derivatives
AU627927B2 (en) Pharmaceutical compositions
PT98823A (pt) Processo para a preparacao de um activador de plasminogenio hibrido
US5234686A (en) Human tissue plasminogen activator consisting essentially of t-PA residues to 160 to 527, pharmaceutical compositions and methods of treatment
NZ257175A (en) Thrombin activated plasminogen derivatives with the cleavage site p4-p3-pro-arg-p1'-p2'
US5908625A (en) Use of the protease domain of human plasminogen activator for the treatment of thromboembolic diseases
WO1992018139A1 (en) Chimeric molecule with plasminogen activator activity and affinity for atherosclerotic plaques
JP2000504941A (ja) トロンビンによって活性化され得るプラスミノーゲンアクチベーター
US6682733B1 (en) Fibrinolytic enzymes
WO1996017928A1 (en) Use of the protease domain of human plasminogen activator for the treatment of thromboembolic diseases
Lin et al. Expression of human factor IX in mammalian cells
Finke et al. MYOCARDIAL SALVAGE BY COMBINED TREATMENT WITH RECOMBINANT SINGLE-CHAIN UROKINASE-TYPE PLASMINOGEN ACTIVATOR AND RECOMBINANT HUMAN SUPEROXIDE DISMUTASE IN A CANINE CORONARY THROMBOSIS MODEL
Berkner et al. EXPRESSION IN MAMMALIAN CELLS OF FUSION PROTEINS BETWEEN HUMAN FACTORS IX AND VII
JPH0775580A (ja) 新規なｔ−ＰＡ改変体
MXPA99000966A (en) Plasminogen activator capable of being activated by thrombin

Legal Events

Date Code Title Description
FF Patent granted
HC Change of name of proprietor(s)
KB Patent renewed
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees